November 28th 2024
Researchers at the University of Colorado Anschutz Medical Campus found that characters with crossed or drifting eyes are more likely to play more minor roles in animated movies and be considered unintelligent or villainous. These depictions, the researchers say, can have harmful effects for children with strabismus by perpetuating stereotypes.
November 28th 2024
November 23rd 2024
November 14th 2024
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data
View More
Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
(CME) Stratifying the Spectrum of Care in Glaucoma Management – Advancing Treatment with a Vast Armamentarium
View More
(CME) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(COPE) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(CME) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(COPE) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(CME) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
(COPE) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (CME Credit)
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (COPE Credit)
View More
SimulatED™: Applying Advanced Treatment for nAMD & DME - Simulating New Strategies for Clinical Management
View More
EnVision Summit
February 14-17, 2025
Register Now!
Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments
March 16, 2025
Register Now!
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Children achieve relief of ocular allergies
March 1st 2005Chicago—Ketotifen fumarate 0.025% ophthalmic solution (Zaditor, Novartis) offers rapid-onset, long-lasting relief of allergy-associated itching along with excellent local tolerability and a long-standing record of safety. Those features combined make it an outstanding therapeutic choice for all patients with allergic conjunctivitis and a particularly attractive option for the pediatric population, said Kimberlee M. Curnyn, MD.
Read More
Clinical focus for incontinentia pigmenti requires redirection
December 1st 2004Coronado Island, CA-The focus of attention in caring for babies with incontinentia pigmenti (IP) should be on the potential for rapid development of irreversible blindness rather than on the clinically obvious skin manifestations, said Morton F. Goldberg, MD, in the Gertrude D. Pyron Award Lecture at the annual meeting of the American Society of Retina Specialists.
Read More
Subconjunctival fibrosis one cause of failed glaucoma filter
October 15th 2004New York -Five potential causes of failure of glaucoma filtration surgery include excessive subconjunctival fibrosis, tight scleral flap sutures, encapsulated bleb, occluded internal ostium, and intraocular obstruction, according to James C. Tsai, MD.
Read More
Early diagnosis essential in cerebrovascular dissections
August 15th 2004Philadelphia-Cerebrovascular dissection represents a life-and-death situation for the patient. Ophthalmologists should be able to recognize this potentially catastrophic diagnosis and initiate emergent treatment, said Nicholas Volpe, MD.
Read More
The pediatric eyewear market may be a rewarding and lucrative off-shoot for ophthalmologists who have already chosen to include a dispensary in their practices. Robert S. Gold, MD, of Eye Physicians of Central Florida, Orlando, offers this advice about including pediatric and youth eyewear in a busy ophthalmologic practice.
Read More
Key factors help clinician assess strabismus, diplopia
August 1st 2004Oklahoma City-When patients with strabismus or diplopia present, ophthalmologists question if the condition is a congenital or an acquired neurologic disease and if imaging or any other tests are needed. R. Michael Siatkowski, MD, differentiated among the various possibilities.
Read More
Weisenfeld Award winner highlights the success behind retinoblasma treatment, survival rate
April 26th 2004One of the few success stories in pediatric oncology, retinoblastomahas ridden scientific and therapeutic advances to a near-100% survival,a 180-degree turnabout from a century ago, said the 2004 recipient of MildredWeisenfeld Award for Excellence in Ophthalmology.
Read More
ARVO 2004 Retina presentations
April 1st 2004Among the 233 sessions dedicated to retina, almost 75 are free papersand symposia sessions. The Editorial Advisory Board of OphthalmologyTimes reviewed the retina abstracts to be presented at this year's meeting.Some of the board's selections are highlighted here.
Read More
Part-, full-time patching equally effective for severe amblyopia
April 1st 2004Rochester, MN-In young children with severe amblyopia, 6 hours of prescribed patching per day appears to be as effective as full-time prescribed patching when both are combined with 1 hour of near activity, according to the recently published results of the Amblyopia Treatment Study of patching regimens for severe amblyopia.
Read More